Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib
about
Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-AnalysisDo renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studiesPrognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysisThe Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort StudiesPrognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis.Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors.Lack of effect of smoking status on axitinib pharmacokinetics in patients with non-small-cell lung cancer.Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib.The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study.Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.Reducing tobacco-related cancer incidence and mortality: summary of an institute of medicine workshop.Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study.Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity
P2860
Q26786160-9CA91207-CC2D-427B-BCAF-B0FEEFED0869Q30235047-F3BF2B00-176C-4B61-9482-FE69CF9F645AQ35332425-032EFCF3-4ECE-449E-A054-D01814062F83Q35858090-830E57B7-65A0-444D-A691-27BC6F837EF1Q37303732-27DB7A2F-FAD8-41EB-B2B4-C7F20282E30CQ37536769-39ABCDF2-2809-42A4-A16D-5D6378E3527BQ39248181-A2740285-F75F-488C-AA1C-A5EA29B21F80Q39628746-27F2CA75-DFD9-4F4F-935A-072D780CEE8BQ40545360-051FD176-7480-41AC-826D-18D353FBC993Q40908884-984914D2-FEB6-41B9-9D6A-C592D8166E88Q42733830-806B98E9-D01F-404C-B325-6CD0D6A513C8Q47863448-FD8BFF10-8175-419F-A64F-7878629A0977Q49635743-5ACB1A00-3F87-445A-906A-FBE1AEF8DF12Q54977664-F09CBDE8-92A8-4A3C-AA3B-64BCCFC96E83Q54996768-6FA71F37-855D-4871-9E52-B7BFBA2385CFQ59125636-B05F6BAD-8166-4C1E-A39F-64B49C4646C0
P2860
Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Active smoking may negatively ...... rcinoma treated with sunitinib
@en
Active smoking may negatively ...... cinoma treated with sunitinib.
@nl
type
label
Active smoking may negatively ...... rcinoma treated with sunitinib
@en
Active smoking may negatively ...... cinoma treated with sunitinib.
@nl
prefLabel
Active smoking may negatively ...... rcinoma treated with sunitinib
@en
Active smoking may negatively ...... cinoma treated with sunitinib.
@nl
P2093
P2860
P1433
P1476
Active smoking may negatively ...... rcinoma treated with sunitinib
@en
P2093
Avishay Sella
Avivit Neumann
Avivit Peer
Ben Boursi
Daniel Keizman
Hans Hammers
Henry Hayat
Keren Rouvinov
Mario A Eisenberger
Maya Gottfried
P2860
P356
10.1634/THEONCOLOGIST.2012-0335
P577
2013-12-05T00:00:00Z